1msx: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Theoretical_model}} | |||
==HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.== | ==HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.== | ||
<StructureSection load='1msx' size='340' side='right' caption='[[1msx]]' scene=''> | <StructureSection load='1msx' size='340' side='right' caption='[[1msx]]' scene=''> | ||
| Line 7: | Line 9: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Theoretical Model]] | |||
[[Category: Dallas, J L]] | [[Category: Dallas, J L]] | ||
[[Category: Guilford, W J]] | [[Category: Guilford, W J]] | ||
Revision as of 12:28, 11 February 2016
 |
HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.
Structural highlights
|
| ||||||||||||||